EXHIBIT 1
---------
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of
1934, as amended, the undersigned agree to the joint filing on behalf of each of
them of a statement on Schedule 13G (including amendments thereto) with respect
to the Common Stock, par value $0.01 per share, of Vion Pharmaceuticals, Inc.,
and further agree that this Joint Filing Agreement shall be included as an
exhibit to such joint filings.
The undersigned further agree that each party hereto is responsible for
the timely filing of such Schedule 13G and any amendments thereto, and for the
completeness and accuracy of the information concerning such party contained
therein; provided, however, that no party is responsible for the completeness or
accuracy of the information concerning any other party making the filing, unless
such party knows or has reason to believe that such information is inaccurate.
IN WITNESS WHEREOF, the parties have executed this Joint Filing
Agreement on February 19, 2004.
XXXXXXX PARTNERS, L.P.
By: XXXXXXX CAPITAL, LLC,
as General Partner
By: /s/ Xxxxxxx Xxxxx
---------------------------------------
Xxxxxxx Xxxxx, Manager
XXXXXXX MANAGEMENT, LLC
By: /s/ Xxxxxxx Xxxxx
---------------------------------------
Xxxxxxx Xxxxx, Manager
XXXXXXX CAPITAL, LLC
By: /s/ Xxxxxxx Xxxxx
---------------------------------------
Xxxxxxx Xxxxx, Manager
/s/ Xxxxxxx Xxxxx
-------------------------------------------
Xxxxxxx Xxxxx
